Sawant S - Search Results

1

Oxidative stress/reactive metabolite gene expression signature in rat liver detects idiosyncratic hepatotoxicants.

Leone A, Nie A, Brandon Parker J, Sawant S, Piechta LA, Kelley MF, Mark Kao L, Jim Proctor S, Verheyen G, Johnson MD, Lord PG, McMillian MK. Leone A, et al. Among authors: sawant s. Toxicol Appl Pharmacol. 2014 Mar 15;275(3):189-97. doi: 10.1016/j.taap.2014.01.017. Epub 2014 Jan 29. Toxicol Appl Pharmacol. 2014. PMID: 24486436

2

Hepatic expression of heme oxygenase-1 and antioxidant response element-mediated genes following administration of ethinyl estradiol to rats.

Morio LA, Leone A, Sawant SP, Nie AY, Parker JB, Taggart P, Barron AM, McMillian MK, Lord P. Morio LA, et al. Toxicol Appl Pharmacol. 2006 Nov 1;216(3):416-25. doi: 10.1016/j.taap.2006.06.016. Epub 2006 Jul 14. Toxicol Appl Pharmacol. 2006. PMID: 16926038

3

Type 2 diabetic rats are sensitive to thioacetamide hepatotoxicity.

Sawant SP, Dnyanmote AV, Warbritton A, Latendresse JR, Mehendale HM. Sawant SP, et al. Toxicol Appl Pharmacol. 2006 Mar 15;211(3):221-32. doi: 10.1016/j.taap.2005.07.019. Epub 2005 Sep 8. Toxicol Appl Pharmacol. 2006. PMID: 16153671

4

Mechanisms of inhibited liver tissue repair in toxicant challenged type 2 diabetic rats.

Sawant SP, Dnyanmote AV, Mehendale HM. Sawant SP, et al. Toxicology. 2007 Apr 11;232(3):200-15. doi: 10.1016/j.tox.2007.01.004. Epub 2007 Jan 14. Toxicology. 2007. PMID: 17298859

5

Potentiation of carbon tetrachloride hepatotoxicity and lethality in type 2 diabetic rats.

Sawant SP, Dnyanmote AV, Shankar K, Limaye PB, Latendresse JR, Mehendale HM. Sawant SP, et al. J Pharmacol Exp Ther. 2004 Feb;308(2):694-704. doi: 10.1124/jpet.103.058834. Epub 2003 Nov 10. J Pharmacol Exp Ther. 2004. PMID: 14610242

6

Diabetic mice are protected from normally lethal nephrotoxicity of S-1,2-dichlorovinyl-L-cysteine (DCVC): role of nephrogenic tissue repair.

Dnyanmote AV, Sawant SP, Lock EA, Latendresse JR, Warbritton AA, Mehendale HM. Dnyanmote AV, et al. Toxicol Appl Pharmacol. 2006 Mar 1;211(2):133-47. doi: 10.1016/j.taap.2005.07.015. Epub 2005 Aug 25. Toxicol Appl Pharmacol. 2006. PMID: 16125744

7

Protective effect of type 2 diabetes on acetaminophen-induced hepatotoxicity in male Swiss-Webster mice.

Sawant SP, Dnyanmote AV, Mitra MS, Chilakapati J, Warbritton A, Latendresse JR, Mehendale HM. Sawant SP, et al. J Pharmacol Exp Ther. 2006 Feb;316(2):507-19. doi: 10.1124/jpet.105.094326. Epub 2005 Oct 5. J Pharmacol Exp Ther. 2006. PMID: 16207833

8

Calpastatin overexpression prevents progression of S-1,2-dichlorovinyl-l-cysteine (DCVC)-initiated acute renal injury and renal failure (ARF) in diabetes.

Dnyanmote AV, Sawant SP, Lock EA, Latendresse JR, Warbritton AA, Mehendale HM. Dnyanmote AV, et al. Toxicol Appl Pharmacol. 2006 Sep 1;215(2):146-57. doi: 10.1016/j.taap.2006.01.018. Epub 2006 Mar 20. Toxicol Appl Pharmacol. 2006. PMID: 16546232

9

Upregulation of calpastatin in regenerating and developing rat liver: role in resistance against hepatotoxicity.

Limaye PB, Bhave VS, Palkar PS, Apte UM, Sawant SP, Yu S, Latendresse JR, Reddy JK, Mehendale HM. Limaye PB, et al. Among authors: sawant sp. Hepatology. 2006 Aug;44(2):379-88. doi: 10.1002/hep.21250. Hepatology. 2006. PMID: 16871587

10

Renal and hepatic transporter expression in type 2 diabetic rats.

Nowicki MT, Aleksunes LM, Sawant SP, Dnyanmote AV, Mehendale HM, Manautou JE. Nowicki MT, et al. Drug Metab Lett. 2008 Jan;2(1):11-7. doi: 10.2174/187231208783478425. Drug Metab Lett. 2008. PMID: 19356064

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

586 results

Search Page

Filters